Cite
HARVARD Citation
Moeller, D. et al. (n.d.). OC-0544: Heterogeneous FDG-guided dose escalation of locally advanced NSCLC, the NARLAL2 phase III trial. Radiotherapy and oncology. pp. S259-. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Moeller, D. et al. (n.d.). OC-0544: Heterogeneous FDG-guided dose escalation of locally advanced NSCLC, the NARLAL2 phase III trial. Radiotherapy and oncology. pp. S259-. [Online].